Implosive Therapy
Unique Therapy
Thermotherapy
Psychotherapy
Relay Treatment
Dietotherapy
Cytoimmunotherapy
Implosive Therapy Group Profile > Implosive Therapy

一、中西医结合冲击疗法
1. Implosive therapy of integrated Chinese and western medicines 
        
“中西医结合冲击疗法”是以提高患者生存质量为前提,将中医整体治疗观与局部治疗有机结合,从改善症状入手,灵活运用中药介入+大剂量抗癌中成药+热疗+细胞治疗等多种治疗手段,辅以食疗、心理疏导和肿瘤康复文化为一体的新型康复模式。扶正祛邪,标本兼治,抑制肿瘤增长,遏制复发转移,延长患者生命。是目前应用广泛、安全高效的临床治疗方法。


Under the premise of improving the survival quality of patients, our implosive therapy organically combines holistic treatment view of TCM with local treatment. By starting from the symptom improvement, it flexibly applies various treatment means (e.g. intervention with TCM medicines, large-dose administration of anti-cancer Chinese patent medicines, thermotherapy and cytoimmunotherapy), which is assisted with a new rehabilitation mode integrating the dietotherapy, psychological catharsis and tumor rehabilitation culture. It can strengthen the vital qi for eliminating pathogenic factor, treat both manifestations and root cause, inhibit the growth of tumors, restrain the recurrence/metastasis of tumors, and prolong the life of patients. At present, our implosive therapy is a safe effective clinical treatment method of wide use.

      冲击疗法的机理效用
 Mechanisms and functions
       冲击疗法是根据中医“去邪而不伤正,养正而不助邪”的治则,把振国系列抗癌药与西医治疗手段和现代生物治疗技术相结合,既倚重西医理论和规范治疗准则,又充分体现中医扶正培本、软坚散结、清热解毒、辩症治疗。
According to the treatment principles of TCM (i.e. eliminate the pathogenic factor by not damaging the vital qi, and nourish the vital qi by not promoting the pathogenic factor), our implosive therapy combines our series of anti-cancer medicines with western treatment means and modern biotherapy technology. It not only stresses the western medicines theories and standard treatment guidelines, but also fully reflects the unique characteristics of TCM (i.e. strengthen the vital qi for cultivating the essence, soften/resolve the hard mass, clear the heat-toxin and treat based on the syndrome differentiation). 
     
通过大量临床应用证实,冲击疗法具有下述机理和效用:
     As verified by numerous clinical applications, our implosive therapy the following mechanisms and functions: 
     
●抑制肿瘤新生血管生长,使肿瘤坏死缩小。当运用冲击疗法治疗后,肿瘤组织周边血管迅速收缩,新生血管受抑制并萎缩,肿瘤组织缺血,肿瘤部位的微循环遭到破坏,导致肿瘤细胞发生继发性坏死,致使肿瘤缩小。
Inhibit the neovascularization of tumors to necrotize and shrink the tumors. Our implosive therapy can rapidly constrict the blood vessels around the tumors and inhibit/atrophy the neovascularization for the ischemia of tumor tissues and the damage of micro-circulation at the tumor site, so as to cause a secondary necrosis of tumor cells and thus a shrinking of tumors.
     
提高机体免疫能力,吞噬肿瘤细胞。振国系列抗癌药中,含有多种提高机体细胞免疫和体液免疫的活性物质,大剂量给药后,能够增强机体内系统吞噬功能和刺激抗体生成,使肿瘤细胞不断被溶解和吞噬。
Improve the body immunity to engulf the tumor cells. In our series of anti-cancer medicines, there are various active compositions to improve the immunity of body cells and body fluid. After their administration at a large dose, the engulfing function of body system is strengthened and the formation of antibody is stimulated, so as to continuously lyse and engulf the tumor cells.
     
杀伤肿瘤细胞,使肿瘤组织钙化、液化。在运用冲击疗法治疗后,可明显增加肿瘤患者自然杀伤肿瘤细胞活性,增强细胞介导的细胞毒作用,导致T杀伤细胞增殖,同时还可诱生较多肿瘤坏死因子,使肿瘤细胞出现自溶,导致肿瘤组织最终钙化或液化。
Kill the tumor cells to calcify and liquefy the tumor tissues. Our implosive therapy can not only obviously improve the natural activity of tumor patients for killing the tumor cells and strengthen the cell-mediated cytotoxic effect to cause a proliferation of T cells, but also induce the formation of more tumor necrosis factors and the autolysis of tumor cells to finally calcify or liquefy the tumor tissues.
     
促使肿瘤细胞周围组织纤维化,阻断转移。当运用冲击疗法治疗后,使肿瘤组织受到高浓度抗癌药物的攻击,使肿瘤外周细胞发生坏死,经过一系列攻击反应将坏死组织分解、吸收,胶原卡蛋白沉积形成纤维化,造成肿瘤病灶周围出现组织纤维化,阻断肿瘤细胞向周边侵润及转移。
Promote the fibrillation of tissues around the tumor cells to block the metastasis. Our implosive therapy can expose the tumor tissues to the high-concentration anti-cancer medicines, so as to necrotize the tissues around the tumor cells. After a series of implosive reactions, the necrotic tissues are decomposed and absorbed and the collagens precipitate into fibrillation, so as to fibrillate the tissues around the tumor foci and block the peripheral infiltration and metastasis of tumor cells.
     
逆转肿瘤细胞的多药耐药性。在振国系列抗癌药中,含有较多人参皂甙Rb1有效成份。当运用冲击疗法治疗后,会使血液中人参皂甙Rb1浓度增多,并有效抑制多药耐药性主要机制P-gp的功能,使肿瘤细胞内的抗肿瘤有效成份增多,通过增加细胞内药物浓度达到逆转多药耐药性,有效杀伤肿瘤细胞。
Reverse the multi-medicine tolerance of tumor cells. In our series of anti-cancer medicines, there are numerous active compositions of ginsenoside Rb1. Our implosive therapy can increase the blood concentration of ginsenoside Rb1 and effectively inhibit the function of P-gp (a main mechanism for multi-medicine tolerance), so as to increase the anti-tumor active compositions in the tumor cells and effectively kill the tumor cells by reverting the multi-medicine tolerance due to the increase of medicine concentration in the tumor cells.
     
加快肿瘤细胞分化与凋亡。在振国系列抗癌药中,所含人参皂甙、猪苓多糖、胆甾醇、榄香烯(莪术的成份)、熊果酸(白花蛇舌草的成份)等多种有效成份,均是目前医药界公认的肿瘤细胞分化诱导剂或促进凋亡的有效成份,当运用冲击疗法治疗后,可使血液中这些有效成份浓度增多,并由此加快了诱导肿瘤细胞分化为正常或接近正常细胞的分化进程和凋亡进程。


Accelerate the differentiation and apoptosis of tumor cells. In our series of anti-cancer medicines, there are many active compositions which is well recognized in the pharmaceutical circle to induce the differentiation of tumor cells or promote their apoptosis, e.g. ginsenoside, polyporusus bellatus polysaccharide, cholesterol, elemene (compositions of zedoray rhizome) and ursolic acid (compositions of hedyotis). Our implosive therapy can increase the blood concentration of these active compositions, so as to accelerate the differentiation and apoptosis of tumor cells into normal or nearly normal cells.


     
缓解恶病质。在振国系列抗癌药中,含有的猪苓多糖有效成份,可有效抑制与发生恶病质紧密关联的毒激素-L。当运用冲击疗法治疗后,使得体内猪苓多糖血药浓度足以有效抑制毒激素-L的作用,从而达到阻遏恶病质的发生和发展,抑制肿瘤增长。
Relieve the cachexia. In our series of anti-cancer medicines, the polyporusus bellatus polysaccharide can effectively inhibit the toxohormone-L, which is closely related to cachexia. Our implosive therapy can achieve a blood concentration of polyporusus bellatus polysaccharide enough to effectively inhibit the toxohormone-L, so as to block the incidence and development of cachexia and thus inhibit the growth of tumors.

     振国医院临床治疗的主要是三大类患者:
     Indications: 
(1)
病情严重体质较弱已失去手术、放化疗机会;
(2)
手术、放化疗后复发者;
(3)
手术或放化疗效果不明显,体内仍有肿瘤病灶者。
(1) Inapplicable for operation, radiotherapy or chemotherapy due to the serious illness and weak constitution; 
(2) Recurrent after the operation, radiotherapy or chemotherapy; 
(3) Unobvious efficacy with tumor foci after the operation or radiotherapy or chemotherapy.
      
其中对食道癌、胃癌、肠癌、肺癌、肝癌、脑癌、乳腺癌、鼻咽癌数千余例患者进行治疗前与治疗后的对照组治疗效果统计分析表明:经过中西医结合冲击疗法、生物治疗、住院治疗的综合有效率达到87.7%

In the studies on several thousands of tumor patients (e.g. esophagus 

cancer, stomach cancer,  intestine cancer, lung cancer, liver cancer, brain 

cancer, breast cancer and nasopharynx  cancer), as compared with those 

in control group, our implosive therapy, cytoimmunotherapy  and intervention

 therapy could achieve an overall effective rate of up to 87.7% for the 

 inpatients. 


    
为什么要坚持中西医结合冲击疗法
Reasons for application
      
长期以来,肿瘤治疗一直处于两难境地。既要快速达到治疗效果,又需要充分考虑到患者治疗毒副反应的承受能力。据统计,70%以上的放化疗患者出现恶心、呕吐、脱发、白细胞急剧减少等毒副反应和溃疡、炎症、低烧等多种并发症。约有1/31/2的肿瘤患者不是死于肿瘤本身,而是死于放化疗引起的并发症;部分重症、体弱的患者因承受不了手术和放化疗对身体造成的伤害而不得不放弃治疗。因此,肿瘤治疗不能“一刀切”,必须“因人而异,因病而异,远近治疗,全面考虑”。
For a long time, the tumor treatment has been in a dilemma between fast efficacy and patient tolerance of toxic/adverse reactions. As shown by statistical data, over 70% of radiotherapy/chemotherapy patients had various toxic/adverse reactions (e.g. nausea, vomiting, alopecia and abrupt leukocytopenia) and various complications (e.g. ulcer, inflammation and low fever); nearly 1/3~1/2 of tumor patients died not of tumor itself but of complications caused by the radiotherapy/chemotherapy; and some patients of serious illness and weak constitution had to quit the treatment because they could not bear the body damage from operation, radiotherapy and chemotherapy. Therefore, the tumor treatment must not be uniform in all cases, but should vary with individual/illness by combing the long/near-term effect and through the overall consideration.
     
如何让肿瘤治疗走出两难境地,中西医结合冲击疗法的问世为肿瘤治疗走出两难找到了突破口。采用中西医结合冲击疗法,将中药抑制肿瘤与西药杀伤肿瘤有机结合,率先突破了中西药各自为政的局面,既强调西医的近期治疗效果,直接杀伤肿瘤细胞,缓解肿瘤患者症状,又注重患者的远期治疗,强调扶正固本,有效提高患者免疫功能,提高患者生存质量。
Our implosive therapy makes a breakthrough point in such dilemma of tumor treatment. It organically combines the tumor inhibition of TCM medicines with the tumor killing of western medicines, and takes the lead in breaking the isolation situation of Chinese and western medicines. It not only stresses the near-term efficacy of western medicines to directly kill the tumor cells and relieve the symptoms of tumor patients, but also emphasizes the long-term efficacy to strengthen the vital qi for consolidating the essence, effectively improve the immunity of tumor patients and improve the survival quality of tumor patients.
     
术前服用抗癌中药可以控制肿瘤生长,减少肿瘤与其它组织粘连,为成功实施手术创造了条件;术后服用抗癌中药,能有效清除体内残留肿瘤细胞,增强患者免疫功能,促进伤口早日愈合,快速恢复患者体质;配合放化疗服用抗癌中药可减轻患者毒副反应,减毒增效;康复期服用抗癌中药对于遏制肿瘤复发转移、提高生存质量效果显著。
Before the operation, the anti-cancer TCM medicines can control the growth of tumors and reduce the adhesion of tumors to other tissues, so as to create a favorable condition for successful operation. After the operation, the anti-cancer TCM medicines can effectively eliminate the residual tumor cells out of body, strengthen the immunity of patients, promote the early heal of wound, and rapidly restore the good constitution of patients. At the combination with radiotherapy or chemotherapy, the anti-cancer TCM medicines can relieve the toxic/adverse reactions in patients, attenuate the toxicity, and improve the efficacy. At the rehabilitation stage, the anti-cancer TCM medicines can restrain the recurrence/metastasis of tumor, and significantly improve the survival quality.

 

 

 

Copyright. 2014  Zhenguo Medical Group  All Rights Reserved 李应鹏 18666900927